Refine by
Cell Count Articles & Analysis
10 news found
Currently, patients with MDS are monitored with blood tests to measure complete blood cell counts and bone marrow analyses to detect the appearance of leukemic blasts heralding the development of AML. ...
Chemotherapy drugs may reduce patients’ platelet and white blood cell counts and weaken their immune systems. This leaves them more vulnerable to wound infections. ...
JELMYTO can affect your bone marrow and can cause a decrease in your white blood cell, red blood cell, and platelet counts. Your healthcare provider will do blood tests prior to each treatment to check your blood cell counts during treatment with JELMYTO. ...
The use of CytoSorb was associated with significantly lower post-operative sepsis-related mortality (7.5% vs. 20% control, p=0.021) and lower levels of C-Reactive Protein (8.8 vs. 9.8 mg/dl; p=0.019) and white blood cell counts (9.8 vs. 11.7 x10-6/mcL; p=0.033) on post-operative day 1. ...
Further, approximately 25% of patients had CD4 cell count of less than 100, indicating advanced HIV disease with highly compromised immunity, who were at high risk of opportunistic diseases and death. ...
It can count, size, and ID therapeutic cell types and determine if non-conforming particles are cellular, protein, or other types of material. ...
Since its founding in 1968, Sysmex has developed its business by focusing on the hematology field (blood cell count tests), which analyzes the number, type, and size of red and white blood cells as well as platelets. Sysmex has adopted a modular concept since the launch of the XN-Series Automated Hematology Analyzer (“XN-Series”) in ...
This includes continued stability of endothelial cell counts as well as rates of persistent inflammation (0.5% Hydrus vs. 2.1% cataract surgery alone). ...
The paper, titled A Novel Approach to Hematology Testing at the Point-Of-Care, compares the traditional analysis methods used for blood cell counting to the new imaging flow cytometry method used by the HemoScreen. ...
A recent study on 36 commercial dairy farms in New Zealand found one herd test within 80 days of the herd drying-off date had “the equivalent test performance” to make decisions on which cows to treat with dry cow therapy as compared to four measures of cell count which is standard practice in NZ. These measures included the maximum ...